AOC1
Amiloride-sensitive amine oxidase [copper-containing]
Protein Summary
Catalyzes the degradation of compounds such as putrescine, histamine, spermine, and spermidine, substances involved in allergic and immune responses, cell proliferation, tissue differentiation, tumor formation, and possibly apoptosis. Placental DAO is thought to play a role in the regulation of the female reproductive function. This gene encodes a metal-binding membrane glycoprotein that oxidatively deaminates putrescine, histamine, and related compounds. The encoded protein is inhibited by amiloride, a diuretic that acts by closing epithelial sodium ion channels. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2013]
- ENST00000360937
- ENSP00000354193
- ENSG00000002726
- ENST00000416793
- ENSP00000411613
- ENST00000467291
- ENSP00000418328
- ENST00000493429
- ENSP00000418614
- ABP1
- DAO1
- ABP
- DAO
- KAO
- ABP1
- DAO1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
molecular function | 1 | ||
protein domain | 0.85 | ||
cell type or tissue | 0.82 | ||
disease | 0.75 | ||
chemical | 0.62 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 683.61 (req: < 5)
Gene RIFs: 22 (req: <= 3)
Antibodies: 356 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 683.61 (req: >= 5)
Gene RIFs: 22 (req: > 3)
Antibodies: 356 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 24
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 10
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 1